Evidence map›Paper›PMID 36677891›Full record

ArticleMolecules (Basel, Switzerland)2023

Comparison of the Cannabinoid and Terpene Profiles in Commercial Cannabis from Natural and Artificial Cultivation.

Fereshteh Zandkarimi, John Decatur, John Casali, Tina Gordon, Christine Skibola, Colin Nuckolls

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Impact of Soil Quality on Cannabinoid and Terpenoid Content ofJournal of medicinally active plants · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Environmental Impact of Outdoor Cannabis Production.ACS agricultural science & technology · 2024
    Article
  10. Article
  11. Review
  12. Antimicrobial, Probiotic, and Immunomodulatory Potential ofAntibiotics (Basel, Switzerland) · 2024
    Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fereshteh ZandkarimiDepartment of Chemistry, Columbia University, New York, NY 10027, USA.
John DecaturDepartment of Chemistry, Columbia University, New York, NY 10027, USA.
John CasaliHuckleberry Hill Farms, 9415 Briceland Rd, Garberville, CA 95542, USA.
Tina GordonMoonmade Farms, P.O. Box 5, Garberville, CA 95542, USA.
Christine SkibolaCosmic View, P.O. Box 1255, Novato, CA 94948, USA.
Colin NuckollsDepartment of Chemistry, Columbia University, New York, NY 10027, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interest in cultivating cannabis for medical and recreational purposes is increasing due to a dramatic shift in cannabis legislation worldwide. Therefore, a comprehensive understanding of the composition of secondary metabolites, cannabinoids, and terpenes grown in different environmental conditions is of primary importance for the medical and recreational use of cannabis. We compared the terpene and cannabinoid profiles using gas/liquid chromatography and mass spectrometry for commercial cannabis from genetically identical plants grown indoors using artificial light and artificially grown media or outdoors grown in living soil and natural sunlight. By analyzing the cannabinoids, we found significant variations in the metabolomic profile of cannabis for the different environments. Overall, for both cultivars, there were significantly greater oxidized and degraded cannabinoids in the indoor-grown samples. Moreover, the outdoor-grown samples had significantly more unusual cannabinoids, such as C4- and C6-THCA. There were also significant differences in the terpene profiles between indoor- and outdoor-grown cannabis. The outdoor samples had a greater preponderance of sesquiterpenes including β-caryophyllene, α-humulene, α-bergamotene, α-guaiene, and germacrene B relative to the indoor samples.

Indexed as

CannabinoidsCannabisHallucinogensCannabinoid Receptor AgonistsGas Chromatography-Mass SpectrometryTerpenesCannabinoid Receptor AgonistsCannabinoidsHallucinogensTerpenescannabinoidscommercial cannabisGC-MSLC-MSterpenes

Identifiers

PMID36677891
PMCPMC9861703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.